• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Myogenic factor 6 (MYF6)

ACP23860

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP23860 Target NameMYF6
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-242Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP23409
Background Information
  • Uniprot Id

    P23409

  • Target Species

    Human

  • Target Name

    MYF6

  • Target Full Name

    Myogenic factor 6

  • Target Function

    Involved in muscle differentiation (myogenic factor). Induces fibroblasts to differentiate into myoblasts. Probable sequence specific DNA-binding protein.

  • Target Involvement

    Myopathy, centronuclear, 3 (CNM3)

  • Target Subcellular Location

    Nucleus.

  • Target Tissue Specificity

    Skeletal muscle.

  • Target Synonyms

    bHLHc4; Class C basic helix-loop-helix protein 4; CNM3; HERCULIN; MRF4; Muscle-regulatory factor 4; Muscle-specific regulatory factor 4; Myf-6; Myf6; MYF6_HUMAN; myogenic factor 6 (herculin); Myogenic factor 6

  • Target Background

    The protein encoded by this gene is a probable basic helix-loop-helix (bHLH) DNA binding protein involved in muscle differentiation. The encoded protein likely acts as a heterodimer with another bHLH protein. Defects in this gene are a cause of autosomal dominant centronuclear myopathy (ADCNM).

Inquire Recombinant Human Myogenic factor 6 (MYF6) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification